Here's What Analysts Are Saying About IDEXX Laboratories (IDXX)

IDEXX Laboratories, Inc. (NASDAQ:IDXX) is one of the best pet stocks to buy according to hedge funds. On February 9, Piper Sandler cut the price target on IDEXX Laboratories, Inc. (NASDAQ:IDXX) to $750 from $775 while maintaining a Neutral rating on the shares. The rating update came after the company’s quarterly results, with the firm telling investors that its updated price target primarily takes into account its updated multiple and rolling forward of estimates to 2027 from 2026.

Barclays also revised the price target on IDEXX Laboratories, Inc. (NASDAQ:IDXX) on February 5, bringing it down to $800 from $850 while keeping an Overweight rating on the shares. It updated the company’s model after the fiscal Q4 report, stating that the fiscal 2026 outlook “underwhelmed.”

In another development, UBS cut the price target on IDEXX Laboratories, Inc. (NASDAQ:IDXX) to $730 from $750 on February 3 and maintained a Neutral rating on the shares. It stated that the print exhibited mixed signals, with early benefits from rising diagnostic use among aging “pandemic puppies” and pricing strength helping maintain a premium. However, fiscal Q4 also raised concerns regarding muted fiscal Q1 growth, slower inVue placements in Year 2, and a softer 2026 gross margin outlook. UBS added that risk/reward appears balanced pending clearer evidence that recent pricing premiums are sustainable, with macro headwinds and fewer near-term margin expansion drivers.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) develops, manufactures, and distributes products and services for the veterinary, animal, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other.

While we acknowledge the potential of IDXX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.